Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multimodal Neuroimaging Genetic Biomarkers of Nicotine Addiction Severity

NCT01867411 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.

NCT NCT01867411
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01867411 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multimodal Neuroimaging Genetic Biomarkers of Nicotine Addiction Severity
Lead sponsor
National Institute on Drug Abuse (NIDA)
Phase
Observational
Overall status
Completed
Start date
November 6, 2013
Completion date
Not reported
Enrollment
159 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nicotine dependence